These findings therefore identify JMJD1A and MALAT1 as important factors for N-Myc-mediated neuroblastoma cell migration, invasion and potentially metastasis, and provide important evidence for further development of more selective and potent JMJD1A/MALAT1 inhibitors for the prevention of tumor metastasis. The gene discussed is MYCN; the disease is neoplasm.